A detailed history of Key F Inancial Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 2,000 shares of TGTX stock, worth $75,100. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$75,100
Previous $46,000 30.43%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021

BUY
$25.27 - $54.9 $50,540 - $109,800
2,000 New
2,000 $104,000
Q2 2020

Aug 07, 2020

SELL
$8.9 - $21.84 $17,800 - $43,680
-2,000 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$7.14 - $15.99 $14,280 - $31,980
2,000 New
2,000 $21,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.